相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。TATA and paused promoters active in differentiated tissues have distinct expression characteristics
Vivekanandan Ramalingam et al.
MOLECULAR SYSTEMS BIOLOGY (2021)
From Genetics to Histomolecular Characterization: An Insight into Colorectal Carcinogenesis in Lynch Syndrome
Martina Lepore Signorile et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Familial Risks and Proportions Describing Population Landscape of Familial Cancer
Kari Hemminki et al.
CANCERS (2021)
The Clinical Spectrum of PTEN Mutations
Lamis Yehia et al.
ANNUAL REVIEW OF MEDICINE, VOL 71, 2020 (2020)
Gastric polyposis and desmoid tumours as a new familial adenomatous polyposis clinical variant associated with APC mutation at the extreme 3′-end
Vittoria Disciglio et al.
JOURNAL OF MEDICAL GENETICS (2020)
A brief history of human disease genetics
Melina Claussnitzer et al.
NATURE (2020)
Discovery of common and rare genetic risk variants for colorectal cancer
Jeroen R. Huyghe et al.
NATURE GENETICS (2019)
Cancer prevention and screening: the next step in the era of precision medicine
Holli A. Loomans-Kropp et al.
NPJ PRECISION ONCOLOGY (2019)
The MAZ transcription factor is a downstream target of the oncoprotein Cyr61/CCN1 and promotes pancreatic cancer cell invasion via CRAF-ERK signaling
Gargi Maity et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
TIMP3 Promoter Methylation Represents an Epigenetic Marker of BRCA1ness Breast Cancer Tumours
Ivana Maleva Kostovska et al.
PATHOLOGY & ONCOLOGY RESEARCH (2018)
PTEN: Tumor Suppressor and Metabolic Regulator
Chien-Yu Chen et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
ESR1-promoter-methylation status in primary breast cancer and its corresponding metastases
Verena Kirn et al.
CLINICAL & EXPERIMENTAL METASTASIS (2018)
NCCN Guidelines® Insights Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017 Featured Updates to the NCCN Guidelines
Mary B. Daly et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2017)
The dark matter of the cancer genome: aberrations in regulatory elements, untranslated regions, splice sites, non-coding RNA and synonymous mutations
Sven Diederichs et al.
EMBO MOLECULAR MEDICINE (2016)
Role of non-coding sequence variants in cancer
Ekta Khurana et al.
NATURE REVIEWS GENETICS (2016)
The association between phosphatase and tensin homolog hypermethylation and patients with breast cancer, a meta-analysis and literature review
Yi-Min Lu et al.
SCIENTIFIC REPORTS (2016)
Esophageal cancer in a family with hamartomatous tumors and germline PTEN frameshift and SMAD7 missense mutations
Scott K. Sherman et al.
CANCER GENETICS (2015)
Induction of Ras by SAF-1/MAZ through a feed-forward loop promotes angiogenesis in breast cancer
Alpana Ray et al.
CANCER MEDICINE (2015)
Functional Variants at the 11q13 Risk Locus for Breast Cancer Regulate Cyclin D1 Expression through Long-Range Enhancers
Juliet D. French et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2013)
Cowden Syndrome and the PTEN Hamartoma Tumor Syndrome: Systematic Review and Revised Diagnostic Criteria
Robert Pilarski et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
The prostate cancer-up-regulated myc-associated zinc-finger protein (MAZ) modulates proliferation and metastasis through reciprocal regulation of androgen receptor
Li Jiao et al.
MEDICAL ONCOLOGY (2013)
MAZ-binding G4-decoy with locked nucleic acid and twisted intercalating nucleic acid modifications suppresses KRAS in pancreatic cancer cells and delays tumor growth in mice
Susanna Cogoi et al.
NUCLEIC ACIDS RESEARCH (2013)
TERT Promoter Mutations in Familial and Sporadic Melanoma
Susanne Horn et al.
SCIENCE (2013)
Novel mutation identified in Cowden syndrome presenting as a gastric adenocarcinoma
Margarida Marques et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2013)
The Use of 18F-FDG PET/CT in Cowden Syndrome to Differentiate Multifocal Gastric Carcinoma From Extensive Benign Gastric Polyposis
William Makis et al.
CLINICAL NUCLEAR MEDICINE (2012)
Myc-associated zinc finger protein (MAZ) is regulated by miR-125b and mediates VEGF-induced angiogenesis in glioblastoma
Michiel Smits et al.
FASEB JOURNAL (2012)
Annotation of functional variation in personal genomes using RegulomeDB
Alan P. Boyle et al.
GENOME RESEARCH (2012)
Promoter hypermethylation in male breast cancer: analysis by multiplex ligation-dependent probe amplification
Robert Kornegoor et al.
BREAST CANCER RESEARCH (2012)
A Clinical Scoring System for Selection of Patients for PTEN Mutation Testing Is Proposed on the Basis of a Prospective Study of 3042 Probands
Min-Han Tan et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2011)
PTEN Level in Tumor Suppression: How Much Is Too Little?
Arkaitz Carracedo et al.
CANCER RESEARCH (2011)
Variants on the promoter region of PTEN affect breast cancer progression and patient survival
Tuomas Heikkinen et al.
BREAST CANCER RESEARCH (2011)
Subtle variations in Pten dose determine cancer susceptibility
Andrea Alimonti et al.
NATURE GENETICS (2010)
A case of Cowden's syndrome presenting with gastric carcinomas and gastrointestinal polyposis
Khalid Al-Thihli et al.
NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY (2009)
Tenets of PTEN tumor suppression
Leonardo Salmena et al.
CELL (2008)
MAZ drives tumor-specific expression of PPAR gamma 1 in breast cancer cells
Xin Wang et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Cowden syndrome -: affected patients with PTEN promoter mutations demonstrate abnormal protein translation
Rosemary E. Teresi et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2007)
MS-MLPA: an attractive alternative laboratory assay for robust, reliable, and semiquantitative detection of MGMT promoter hypermethylation in gliomas
Judith Wm Jeuken et al.
LABORATORY INVESTIGATION (2007)
Comparative genomic and functional analyses reveal a novel cis-acting PTEN regulatory element as a highly conserved functional E-box motif deleted in Cowden syndrome
Marcus G. Pezzolesi et al.
HUMAN MOLECULAR GENETICS (2007)
Distinct expression profiles for PTEN transcript and its splice variants in Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome
Marta S. Sarquis et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2006)
DNA hypermethylation of TIMP3 gene in invasive breast ductal carcinoma
ELH Lui et al.
BIOMEDICINE & PHARMACOTHERAPY (2005)
Down-regulation of PTEN expression due to loss of promoter activity in human hepatocellular carcinoma cell lines
Dong-Zhu Ma et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2005)
Hereditary cancer predisposition syndromes
JE Garber et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Frequent inactivation of PTEN by promoter hypermethylation in microsatellite instability-high sporadic colorectal cancers
A Goel et al.
CANCER RESEARCH (2004)
Germline PTEN promoter mutations and deletions in Cowden/Bannayan-Riley-Ruvalcaba syndrome result in aberrant PTEN protein and dysregulation of the phosphoinositol-3-kinase/Akt pathway
XP Zhou et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2003)
Promoter methylation and silencing of PTEN in gastric carcinoma
YH Kang et al.
LABORATORY INVESTIGATION (2002)